End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 JOD | 0.00% | 0.00% | +6.58% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 5.808 | 20.21 | 21.26 | 25.9 | 8.712 | 8.828 |
Enterprise Value (EV) 1 | 9.574 | 23.48 | 24.24 | 28.7 | 9.262 | 11.29 |
P/E ratio | 22.9 x | 935 x | 267 x | 99.5 x | 18.5 x | 90.3 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.43 x | 1.46 x | 1.72 x | 2.3 x | 0.71 x | 0.64 x |
EV / Revenue | 0.7 x | 1.7 x | 1.96 x | 2.55 x | 0.75 x | 0.82 x |
EV / EBITDA | 30.1 x | 38 x | 39.6 x | 41.9 x | 8.98 x | 15.2 x |
EV / FCF | 4.97 x | 42.6 x | 82.1 x | 348 x | 4.45 x | -5.89 x |
FCF Yield | 20.1% | 2.35% | 1.22% | 0.29% | 22.5% | -17% |
Price to Book | 0.94 x | 3.27 x | 3.39 x | 3.97 x | 1.24 x | 1.31 x |
Nbr of stocks (in thousands) | 11,616 | 11,616 | 11,616 | 11,616 | 11,616 | 11,616 |
Reference price 2 | 0.5000 | 1.740 | 1.830 | 2.230 | 0.7500 | 0.7600 |
Announcement Date | 31/03/19 | 03/06/20 | 15/04/21 | 31/03/22 | 30/03/23 | 30/03/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 13.64 | 13.82 | 12.37 | 11.26 | 12.33 | 13.7 |
EBITDA 1 | 0.3183 | 0.6174 | 0.6116 | 0.6855 | 1.032 | 0.7438 |
EBIT 1 | 0.0207 | 0.363 | 0.3312 | 0.4358 | 0.7889 | 0.5053 |
Operating Margin | 0.15% | 2.63% | 2.68% | 3.87% | 6.4% | 3.69% |
Earnings before Tax (EBT) 1 | -0.3483 | 0.0246 | 0.0691 | 0.2738 | 0.5831 | 0.1589 |
Net income 1 | 0.2533 | 0.0216 | 0.0797 | 0.2604 | 0.4721 | 0.0978 |
Net margin | 1.86% | 0.16% | 0.64% | 2.31% | 3.83% | 0.71% |
EPS 2 | 0.0218 | 0.001860 | 0.006862 | 0.0224 | 0.0406 | 0.008415 |
Free Cash Flow 1 | 1.925 | 0.5511 | 0.2952 | 0.0823 | 2.081 | -1.917 |
FCF margin | 14.11% | 3.99% | 2.39% | 0.73% | 16.88% | -13.99% |
FCF Conversion (EBITDA) | 604.59% | 89.27% | 48.26% | 12.01% | 201.67% | - |
FCF Conversion (Net income) | 759.96% | 2,550.28% | 370.31% | 31.62% | 440.79% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 31/03/19 | 03/06/20 | 15/04/21 | 31/03/22 | 30/03/23 | 30/03/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 3.77 | 3.27 | 2.98 | 2.79 | 0.55 | 2.46 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 11.83 x | 5.29 x | 4.872 x | 4.074 x | 0.5328 x | 3.303 x |
Free Cash Flow 1 | 1.92 | 0.55 | 0.3 | 0.08 | 2.08 | -1.92 |
ROE (net income / shareholders' equity) | 3.4% | 0.35% | 1.28% | 4.07% | 6.98% | 1.46% |
ROA (Net income/ Total Assets) | 0.09% | 1.76% | 1.62% | 2.13% | 3.91% | 2.47% |
Assets 1 | 266.9 | 1.229 | 4.92 | 12.23 | 12.07 | 3.956 |
Book Value Per Share 2 | 0.5300 | 0.5300 | 0.5400 | 0.5600 | 0.6000 | 0.5800 |
Cash Flow per Share 2 | 0.0300 | 0.0500 | 0.0400 | 0.0500 | 0.1300 | 0.0700 |
Capex 1 | 0.6 | 0.56 | 0.05 | 0.08 | 0.05 | 0.22 |
Capex / Sales | 4.39% | 4.03% | 0.42% | 0.73% | 0.38% | 1.58% |
Announcement Date | 31/03/19 | 03/06/20 | 15/04/21 | 31/03/22 | 30/03/23 | 30/03/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+6.58% | 13.27M | |
-20.00% | 464M |
- Stock Market
- Equities
- NDAR Stock
- Financials Nutridar Company